Exogenous FGF21 treatment improves glucose homeostasis and prevents hyperglycaemia and diabetes in NZO mice, a model of polygenetic obesity and type 2 diabetes with the characteristic trait of pancreatic beta cell loss [11, 15]. Here, FGF21 is linked to diabetes mellitus.